Aura Biosciences, Inc.
AURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $300 | $300 | $0 | $291 |
| Gross Profit | -$300 | -$300 | $0 | -$291 |
| % Margin | – | – | – | – |
| R&D Expenses | $22,178 | $22,882 | $23,343 | $22,334 |
| G&A Expenses | $0 | $5,731 | $5,692 | $0 |
| SG&A Expenses | $5,428 | $5,731 | $5,692 | $5,182 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$300 | $0 | $0 |
| Operating Expenses | $27,606 | $28,313 | $29,035 | $27,516 |
| Operating Income | -$27,906 | -$28,613 | -$29,035 | -$27,807 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,802 | $1,642 | $1,570 | $1,997 |
| Pre-Tax Income | -$26,104 | -$26,971 | -$27,465 | -$25,810 |
| Tax Expense | $26 | $48 | $18 | $24 |
| Net Income | -$26,130 | -$27,019 | -$27,483 | -$25,834 |
| % Margin | – | – | – | – |
| EPS | -0.4 | -0.47 | -0.55 | -0.52 |
| % Growth | 14.9% | 14.5% | -5.8% | – |
| EPS Diluted | -0.4 | -0.47 | -0.55 | -0.52 |
| Weighted Avg Shares Out | 65,937 | 58,016 | 50,126 | 49,650 |
| Weighted Avg Shares Out Dil | 65,937 | 58,016 | 50,126 | 49,650 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,815 | $1,678 | $1,594 | $2,034 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $300 | $300 | $291 | $291 |
| EBITDA | -$25,804 | -$26,671 | -$28,744 | -$25,519 |
| % Margin | – | – | – | – |